PACS Group's stock plummeted 9.52% during intraday trading on Friday, as investors reacted to concerning disclosures in the company's annual financial report.
The healthcare provider reported strong fiscal year 2025 results, with net income soaring 245.9% to $191.5 million and total revenue increasing 29.3% to $5.3 billion. However, the company disclosed material weaknesses in its internal control over financial reporting, specifically tied to revenue processes.
PACS Group also stated that its disclosure controls were not effective as of December 31, 2025, though it outlined ongoing remediation efforts under Audit Committee oversight. These control issues appear to have overshadowed the positive earnings results in Friday's trading session.
Comments